Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Weight

Showing results (111-120 of 176) with videos related to

Pageof 18
Sort By:
Cancer|January 8, 2009
Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary seriesChristopher J Weight, Jorge A Garcia, Donna E Hansel, et al.
Urologic Oncology|October 8, 2025
Clinical and histological predictors of treatment outcomes in primary urethral carcinomaBetty Wang, Devika Nandwana, Laura E Davis, et al.
Urologic Oncology|December 22, 2023
Oncologic outcomes of intravesical therapy in the management of nonmuscle invasive bladder cancer with variant histologyZaeem Lone, Tarik Benidir, Andrew Wood, et al.
Journal of Virology|May 1, 2009
Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancerSeunghee Hong, Eric A Klein, Jaydip Das Gupta, et al.
The American Journal of Surgical Pathology|February 25, 2025
Atypical Intraductal Proliferation in Prostate Needle Core Biopsy: Validation as a Marker of Unsampled Adverse Pathology in a Clinicopathologic Series of 142 New PatientsRoshan Bhattarai, Jesse K McKenney, Reza Alaghehbandan, et al.
Chemical Research in Toxicology|January 9, 2024
Screening DNA Damage in the Rat Kidney and Liver by Untargeted DNA AdductomicsNagarjunachary Ragi, Scott J Walmsley, Foster C Jacobs, et al.
BJU International|April 2, 2026
Reducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approachJayant Siva, Can Aydogdu, Nicholas Heller, et al.
Annals of Surgical Oncology|October 13, 2018
Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and UrologistsSimon P Kim, Cary P Gross, Nilay D Shah, et al.
Chemical Research in Toxicology|March 18, 2024
Correction to "Screening DNA Damage in the Rat Kidney and Liver by Untargeted DNA Adductomics"Nagarjunachary Ragi, Scott J Walmsley, Foster C Jacobs, et al.
The Journal of Urology|October 23, 2012
Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-AnalysisSimon P Kim, M Hassan Murad, R Houston Thompson, et al.
Pageof 18

Showing results (111-120 of 176) with videos related to

Sort By:
Pageof 18
Cancer|January 8, 2009
Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary seriesChristopher J Weight, Jorge A Garcia, Donna E Hansel, et al.
Urologic Oncology|October 8, 2025
Clinical and histological predictors of treatment outcomes in primary urethral carcinomaBetty Wang, Devika Nandwana, Laura E Davis, et al.
Urologic Oncology|December 22, 2023
Oncologic outcomes of intravesical therapy in the management of nonmuscle invasive bladder cancer with variant histologyZaeem Lone, Tarik Benidir, Andrew Wood, et al.
Journal of Virology|May 1, 2009
Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancerSeunghee Hong, Eric A Klein, Jaydip Das Gupta, et al.
The American Journal of Surgical Pathology|February 25, 2025
Atypical Intraductal Proliferation in Prostate Needle Core Biopsy: Validation as a Marker of Unsampled Adverse Pathology in a Clinicopathologic Series of 142 New PatientsRoshan Bhattarai, Jesse K McKenney, Reza Alaghehbandan, et al.
Chemical Research in Toxicology|January 9, 2024
Screening DNA Damage in the Rat Kidney and Liver by Untargeted DNA AdductomicsNagarjunachary Ragi, Scott J Walmsley, Foster C Jacobs, et al.
BJU International|April 2, 2026
Reducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approachJayant Siva, Can Aydogdu, Nicholas Heller, et al.
Annals of Surgical Oncology|October 13, 2018
Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and UrologistsSimon P Kim, Cary P Gross, Nilay D Shah, et al.
Chemical Research in Toxicology|March 18, 2024
Correction to "Screening DNA Damage in the Rat Kidney and Liver by Untargeted DNA Adductomics"Nagarjunachary Ragi, Scott J Walmsley, Foster C Jacobs, et al.
The Journal of Urology|October 23, 2012
Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-AnalysisSimon P Kim, M Hassan Murad, R Houston Thompson, et al.
Pageof 18